ClinicalTrials.Veeva

Menu

Comparison of Frailty Screening Performance and Predictive Validity of Adverse Health Outcomes in Breast Cancer Patients Using Frailty Screening Tools (frailty)

J

Ju Qiu

Status

Enrolling

Conditions

Frailty Syndrome

Study type

Observational

Funder types

Other

Identifiers

NCT06467149
he Humanities and Social Scien (Other Identifier)
qiujuchongyi

Details and patient eligibility

About

This study uses the Physical Frailty Phenotype (PFP) as the diagnostic criterion for frailty and aims to explore the frailty screening scale FRAIL (The FRAIL Scale), Tilburg Frailty Index (TFI) and geriatric screening. Screening performance of Tool-8 (Geriatric-8, G-8) in breast cancer patients, to compare the predictive validity of different frailty screening scales for adverse health outcomes in breast cancer patients, and to select appropriate frailty screening methods for breast cancer patients in my country Screening scale.

Enrollment

500 estimated patients

Sex

All

Ages

50+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Clinical diagnosis of breast cancer
  • Age ≥50 years old
  • the treatment plan discussed by MDT includes surgery and chemotherapy
  • can walk on their own (with the assistance of walking aids)

Exclusion criteria

  • Communication disorders
  • Mental disorders that can't cooperate normally
  • Combined with other malignant tumours
  • Terminal stage of the disease

Trial design

500 participants in 1 patient group

To select a suitable frailty screening scale for future frailty screening of breast cancer patients
Description:
Only basic inquiries and measurements are performed on the patient, without any intervention.

Trial contacts and locations

1

Loading...

Central trial contact

ju qiu, Bachelor.; lin zeng

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems